Search

Search Results
Results 4561 - 4570 of 4896 for Movement Disorder
  • Prezcobix
    Drug - 3 Jun 2025
    Consumer Medicine Information (CMI) about Prezcobix intended for persons living in Australia.
  • Tobrex
    Drug - 2 Jun 2025
    Consumer Medicine Information (CMI) about Tobrex intended for persons living in Australia.
  • Vasocardol
    Drug - 16 May 2025
    Consumer Medicine Information (CMI) about Vasocardol intended for persons living in Australia.
  • Diltiazem Sandoz CD
    Drug - 16 May 2025
    Consumer Medicine Information (CMI) about Diltiazem Sandoz CD intended for persons living in Australia.
  • Cardizem CD and Cardizem
    Drug - 16 May 2025
    Consumer Medicine Information (CMI) about Cardizem CD and Cardizem intended for persons living in Australia.
  • Remicade
    Drug - 9 May 2025
    Consumer Medicine Information (CMI) about Remicade intended for persons living in Australia.
  • Opdualag
    Drug - 30 Apr 2025
    Consumer Medicine Information (CMI) about Opdualag intended for persons living in Australia.
  • Walking After Meals: Small Habit, Big Metabolic Gains
    Health - 29 Apr 2025
    Short walks post-meal enhance metabolic health, lowering blood sugar levels and supporting long-term glycemic control without the need for intense exercise.
  • Ceftriaxone Viatris
    Drug - 31 Mar 2025
    Consumer Medicine Information (CMI) about Ceftriaxone Viatris intended for persons living in Australia.
  • The Future of Hospital Care with Smart Bed Technology
    Health - 12 Mar 2025
    Smart beds integrate IoT and AI technologies, offering real-time monitoring of patients' vital signs and enhancing safety and comfort in healthcare settings.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback